Background: Breast cancer is the most frequently diagnosed cancer and the leading cause of cancer-related death among women worldwide. Herein, we examine global trends in female breast cancer rates using the most up-to-date data available.
Introduction
Breast cancer is the most commonly diagnosed cancer among women in the vast majority (140/184) of countries worldwide, representing a quarter of all cancers diagnosed in women (1) . It is also the leading cause of cancer-related deaths among women (2) . Although once primarily considered a disease of Western women, over half (52%) of new breast cancer cases and 62% of deaths occur in economically developing countries (3) . In this article, we examine global patterns and trends in female breast cancer incidence and mortality rates using the most up-to-date cancer registry-based data available.
Materials and Methods
Estimated numbers of new breast cancer cases, cancer deaths, incidence and mortality rates, and 5-year prevalence for 2012 by world region and country were compiled by the International Agency for Research on Cancer (IARC) and obtained from GLO-BOCAN (4) . GLOBOCAN provides estimates of cancer incidence, mortality, and prevalence for countries and world regions. Regional estimates of breast cancer incidence and mortality rates are the population-weighted averages of incidence and mortality rates of the component countries. Incidence data are derived from population-based cancer registries that vary in coverage and may capture the population of an entire country but more often cover smaller areas, such as major cities. Mortality data are collected annually by the World Health Organization, and while there is national coverage, not all countries achieve the same quality or completeness. Detailed information about sources and methods for GLOBOCAN 2012 incidence and mortality estimates, including estimation methods for countries that lack incidence and/or mortality data, is available online (globocan.iarc.fr) and reviewed by Ferlay and colleagues (1) . We calculated mortality to incidence rate ratios by region as a proxy of 5-year survival (5) .
Using data extracted from the Cancer Incidence in Five Continents series (6), we present local and national observed incidence rates from population-based cancer registries from 39 countries for [2006] [2007] , as these are the most current years of data available for the majority of countries. Breast cancer mortality rates from 59 countries for 2008-2012 were extracted from the World Health Organization (WHO) Mortality database (7) . The long-term data series from cancer registries and the WHO mortality database were used to assess the respective trends in incidence and mortality rates from 1993 onward in 39 and 56 countries (4, (8) (9) (10) (11) (12) . In addition, we include breast cancer mortality data from Egypt from 2000 to 2011. All rates are per 100,000 females and were standardized using the direct method and the 1960 World standard population to compare data across countries and over time (13) . Our analysis was limited to invasive female breast cancers defined by ICD-10/ICD-O-3 site code C50.
Temporal trends in breast cancer rates by country were analyzed using Joinpoint regression analysis, which involves fitting a series of joined straight lines on a logarithmic scale to the trends in annual rates (14, 15) . We required a minimum of four years between joinpoints and from a joinpoint to either end of the data series. The direction and magnitude of the resulting trends are described by the annual percent change (APC). To facilitate comparison across countries and to evaluate the most recent time trends, a summary measure, the average annual percent change (AAPC), was calculated for the latest 5 years of available data for each country. A detailed description of this method is provided elsewhere by Clegg and colleagues (16) . In describing the change, the terms increase or decrease were used when the APC or AAPC was statistically significant; otherwise the term stable was used.
Results

Geographic variation
Almost 1.7 million new breast cancer cases and 521,900 breast cancer deaths were estimated to have occurred in 2012 worldwide ( Table 1 ). The distribution of breast cancer cases, deaths, and 5-year prevalence by world region is shown in Fig. 1 . Asian countries, which represent 59% of the global population, accounted for 39% of new cases, 44% of deaths, and 37% of the world's 5-year prevalent cases. Although North America (US and Canada) represents only 5% of the world population, it accounted for 15% of new cases, 9% of deaths, and 17% of the prevalent cases. In contrast, African countries (15% of the world population) represented 8% of the total new cases and 12% of breast cancer deaths, and 7% of the prevalence.
Estimated age-standardized breast cancer incidence rates in 2012 varied 3-fold worldwide, with the highest incidence rates observed in Northern America, Northern and Western Europe, and Australia/New Zealand; intermediate rates in Central and Eastern Europe, Southern America, and the Caribbean; and the lowest rates in Middle and Eastern Africa, Eastern and SouthCentral Asia, and Central America (Table 1 ; Supplementary Fig.  S1 ). Similarly, there was approximately 3-fold variation in breast cancer death rates in 2012; however, the highest death rates were observed in Western and Northern Africa and Melanesia and the lowest death rates were found in Central America and Eastern Asia. Rate ratios comparing mortality rates to incidence rates for world regions are also shown in Table 1 . The highest mortality to incidence rate ratios were in parts of Africa (Middle, Western, and Eastern), Melanesia, and South-Central Asia. Rate ratios were lowest in Northern America, Australia/New Zealand, and in Northern and Western Europe.
Observed age-standardized incidence rates in 2006-2007 are presented in Fig. 2 
Incidence and mortality trends
Trends in breast cancer incidence and mortality rates for selected countries are shown in Fig. 4 and in Tables 2 and 3 . Increasing breast cancer incidence trends during the most recent time period were observed in 22 of 39 countries, with 5-year AAPCs ranging from 0.8% in the Netherlands to 4.8% or more in Thailand (3 registries) and Uganda (Kyadondo County) ( Table 2 ). In five countries [France (6 registries), Israel, Italy (8 registries), Spain (7 registries), and Norway], breast cancer incidence rates decreased 0.8%-1.6% per year and in 12 others, primarily in Northern America, Oceania, and Europe, incidence rates were stable ( Table 2 ). In contrast to incidence trends, death rates significantly decreased in the most recent period in 34 of 57 countries analyzed, with AAPCs during the last 5 years ranging from À0.5% in Costa Rica and Lithuania to À3.6% in Iceland (Table 3 ). In ten countries (Brazil, Colombia, Ecuador, Egypt, Guatemala, Japan, Kuwait, Mauritius, Mexico, and Republic of Moldova), breast cancer death rates increased (0.2%-3.5% per year) during the most recent five years of data available (Table 3) . Trends for specific countries/regions are described in more detail below.
Northern America and Oceania
In the United States, Canada (except Quebec), Australia, and New Zealand, the most recent data indicate that breast cancer incidence rates have stabilized, while mortality rates continued to decline.
Central and Southern America and the Caribbean
Local and national incidence data from Central and Southern America and the Caribbean suggest breast cancer incidence rates continued to increase since 1993 in 3 [Colombia (Cali), Costa Rica, and Ecuador (Quito)] of 4 countries included in the study. In Brazil, there was no significant change in incidence rates over this period. Mortality trends in this region are variable. Since 1993, breast cancer death rates increased in Colombia, Ecuador, 
Northern Europe
Incidence and mortality trends diverged in five Northern European countries (Denmark, Estonia, Finland, Iceland, and Lithuania), with incidence rates increasing and mortality decreasing since the mid-1990s. In Latvia, Sweden, and the United Kingdom, increasing incidence trends were also observed; however, incidence rates stabilized in the most recent period in Sweden and the UK. In contrast, incidence rates decreased in Norway by 1.2% per year from 2002 to 2010. Of the 10 countries in Northern Europe in this analysis, death rates decreased since the mid-1990s in all except Latvia, where rates were stable since 2002. Despite the steady decrease in mortality rates by 2.9% per year from 1996 to 2012, Denmark has one of the highest breast cancer death rates in the region (Fig. 3) .
Western Europe
Incidence rates increased over the entire study period in Germany (Saarland) and The Netherlands. Incidence rates also increased in France (6 registries) and Switzerland (6 registries) in the beginning of the study period, but subsequently declined in France (1.2% per year since 2003) and stabilized in Switzerland (since 2000). Breast cancer incidence rates were stable in Austria during 1993-2007. In contrast to the incidence trends, breast cancer death rates decreased in all six Western European countries in the study.
Southern Europe
Similar to France, incidence trends reversed over the study period in Italy and Spain, with rates decreasing since 1999 and 2002, respectively. Incidence rates continued to increase in Croatia and Slovenia since 1993 and were stable over the entire period in Malta. Death rates decreased in six of seven Southern European countries; the trend was stable in Croatia.
Eastern Europe
Incidence rates increased (1.7%-2.2% per year) from 1993 to 2007/2008 in all four Eastern European countries considered in the incidence trend analysis. Trends in death rates in Eastern Europe were variable. In Romania and the Russian Federation, death rates declined since the early 2000s, after previously increasing. Breast cancer death rates also decreased over the study period in Hungary and Slovakia, but they were stable in Bulgaria and Ukraine since 1993 and in Czech Republic since 2009. In contrast, in the Republic of Moldova, breast cancer death rates increased by 1.2% per year from 1998 to 2012.
Asia
Breast cancer incidence rates increased sharply since 1993 in China (3 registries), Japan (4 registries), and Thailand (3 registries). In Singapore, incidence rates increased through 2002 and then stabilized. An increasing incidence trend was also observed in India beginning in 2000. In contrast, incidence rates decreased by 1.6% per year from 1999 to 2007 in Israel. Breast cancer death rates also decreased in Israel. Death rates increased in Japan and Kuwait over the study period and in Kazakhstan and Republic of Korea through 1999 and 2005, respectively. Death rates were relatively stable over the entire study period in China (Hong Kong), Kyrgyzstan, and Singapore.
Africa
Limited data are available for African countries: one metropolitan registry (Uganda, Kyadondo County) for incidence and three countries for mortality. Breast cancer incidence rates increased in Uganda 
Discussion
The highest breast cancer incidence rates continue to be observed in high-income countries, including countries in Northern America, Australia, and Northern and Western Europe, with intermediate rates in Central and Eastern Europe, Southern America, and the Caribbean, and the lowest incidence rates in Middle and Eastern Africa, Eastern and South-Central Asia, and Central America. Of the 32 countries with both incidence and mortality breast cancer data, rates diverged in nine countries mainly in Northern and Western Europe (Costa Rica, Denmark, Estonia, Finland, Germany, Iceland, Lithuania, Slovenia, and the Netherlands). Both incidence and mortality rates decreased in the recent period in Norway, France, Italy, Spain, and Israel, whereas they increased in Colombia, Ecuador, and Japan. The wide geographic and temporal variations in breast cancer rates and trends reflect differences in the patterns of risk factors and access to and availability of early detection and timely treatment.
Rate ratios were used to compare breast cancer mortality rates to incidence rates by region. The highest rate ratios (corresponding to the poorest survival) were in Africa, South-Central Asia, and Melanesia. A recent worldwide study of cancer survival found that breast cancer 5-year net survival ranged from 53% in South Africa to 89% in the United States (17) . In general, high ratios in low-and middle-income countries reflect the large proportion of women presenting with advanced disease and limited access to affordable quality cancer treatment (18) . In many low-income countries, screening is neither cost-effective nor feasible, and access to healthcare is limited, thus the majority of breast cancer patients are diagnosed with advanced stage disease. For example, during 2009-2010, 76% of breast cancer patients in Nigeria were diagnosed with stage III or IV breast cancer (19) . The lowest ratios were observed in Northern America, Australia/New Zealand, and in Western and Northern Europe reflecting moderate death rates despite high incidence rates. Countries with lower breast cancer death rates despite higher incidence rates in part reflect the more favorable survival as a result of earlier stage at diagnosis and greater access to effective cancer treatments (20) . Breast cancer incidence rates have continued to rise in several high-income countries, particularly in Northern and Eastern Europe, as well as in many countries of Latin America, Africa, and Asia, regions with historically lower breast cancer rates. Increasing trends in breast cancer incidence in high-income countries over the past several decades are thought to reflect increases in the prevalence of known risk factors (e.g., reproductive patterns and obesity) and increased detection through mammography (20, 21) . Increases in the use of postmenopausal hormone therapy may have also contributed to the increases in breast cancer incidence rates through the early 2000s (22) (23) (24) (25) (26) (27) (28) . Although mammography screening is currently the most effective method for detecting breast cancer at an early stage, it also results in the overdiagnosis of some breast cancers. Estimates of overdiagnosis are highly variable, ranging from <5% to >30% (29) (30) (31) (32) (33) (34) (35) .
Similarly, the increasing incidence trend in low-and middleincome countries is due largely to increases in risk factors associated with economic development and urbanization, including obesity and adaptation of a Western-type diet, physical inactivity, delayed childbearing and/or having fewer children, earlier age at menarche, and shorter duration of breastfeeding (20, (36) (37) (38) (39) (40) (41) (42) (43) (44) . For example, average body mass index (BMI) among women has increased over the past several decades in many countries around the world, such as in Costa Rica where the average female BMI increased from 23.3 in 1980 to 27.1 in 2008 (45, 46) . Increased access to contraceptives and other voluntary family planning initiatives have led to sustained declines in fertility rates in Asia, Latin America, and Africa (47) . Increased awareness of the disease may also contribute to rising incidence rates in low and middleincome countries.
Incidence rates declined in the recent period in five highincome countries (France, Israel, Italy, Norway, and Spain) and rates were stable in 13 other countries. Previous studies have documented a decline in breast cancer incidence in a several highincome countries related to decreased use of menopausal hormone therapy around the early 2000s (22) (23) (24) (25) (26) (27) (28) . In the United States, breast cancer incidence rates dropped nearly 7% between 2002 and 2003, coinciding with the publication of the results of Women's Health Initiative trial on the adverse health effects of menopausal hormone therapy use in postmenopausal women (48) . The continued decline or stabilization in some Western countries has also been attributed to plateaus in participation of mammography screening (20, 22) .
Although breast cancer incidence rates continued to increase or stabilize in many countries, mortality rates have declined in 34 of 57 countries in the most recent time period (Table 3) . Most of the decreasing trends, as well as the most rapid declines, occurred in high-income countries. These reductions have been attributed to early detection through mammography and improved treatment; although the respective contributions of each are unclear and likely vary depending on the level of participation in regular screening and the availability and prompt administration of state-of-the-art treatment (21, (49) (50) (51) (52) (53) (54) . A study of cancer survival in 67 countries reported that 5-year breast cancer survival increased steadily in most high-income countries, as well as in several countries in Central and Southern America (17) .
In contrast to the decreasing trends observed in most countries, breast cancer mortality rates increased in ten countries (Brazil, Colombia, Ecuador, Egypt, Guatemala, Japan, Kuwait, Mauritius, Mexico, and Republic of Moldova) reflecting increasing incidence trends and in some cases, limited access to treatment (55, 56) . Increasing mortality rates in Asia, Latin America, and Africa have been previously documented (38, (57) (58) (59) . It has been reported that the increase in breast cancer death rates in Japan began in the 1960s, approximately 10 years after the country experienced a transition from a traditional Asian plant-based diet to a Western meat-based diet and subsequently an increase in the prevalence of overweight and obesity (58) . In addition, even in some highincome countries such as Japan, mammography screening has not been widely embraced at a population level for reasons including cultural attitudes toward screening, lack of knowledge and/or encouragement from family and physician, and concerns about modesty (60) .
Optimal breast cancer treatment is often not available in lowincome countries. Effective treatment may be limited by small numbers of trained medical personnel, insufficient modern equipment, including pathology services and radiotherapy machines, and the high cost of cancer drugs (18) . There are currently more than 25 countries, primarily in Africa, without a single radiotherapy unit (61) . The International Atomic Energy Agency (IAEA) has estimated that there is a shortage of at least 5,000 radiotherapy machines in developing countries (62) . There are also social barriers such as fatalistic beliefs, reluctance or refusal to have one's breasts examined by a male doctor, and the stigma associated with breast cancer and its treatment (63) . Cancer fatalism has been documented in Latin American, Arabic, and Ethiopian populations (64) (65) (66) . In some societies, a woman may avoid revealing that she has breast cancer out of fear that she will be rejected by her family and community or that her daughter's potential for future marriage may be adversely affected. For these reasons, cancer education regarding the importance of early detection is fundamental to a successful breast cancer control program in lower-and middle-income countries.
This study is a comprehensive and up-to-date analysis of breast cancer incidence and mortality trends in the most recent time period using cancer incidence and mortality data from IARC and WHO (4, 7) . It should be noted that the 2012 regional estimates presented from GLOBOCAN 2012 are aggregated from those for 184 countries and territories that are variable in accuracy, depending on the extent and validity of available data. Country estimates range from real and valid counts of cases and deaths to estimates based on samples or neighboring country rates. In addition, breast cancer is increasingly understood as a heterogeneous disease made up of a number of histologic and molecular subtypes that are distinct in etiology, presentation, and outcomes (67); however, information on breast cancer subtypes is not available in GLOBOCAN. Despite these limitations, GLOBOCAN 2012 represents the best estimates available and is useful for establishing Cancer Epidemiology, Biomarkers & Preventionpriorities for cancer control in many low and middle-income countries where information for cancer cases and deaths are lacking or limited. Another limitation is that our presentation of overall rates for countries may obscure the breast cancer burden in specific racial and ethnic populations within countries. Breast cancer trends were also likely to be influenced by demographic changes within countries and regions, such as the immigration of low-risk populations in to high-risk countries (68) . Finally, the reporting of trends was limited by the number of countries with sufficient historical data and by the variation in the range of most recent years of available data.
Conclusions
Breast cancer incidence and mortality rates are increasing in some parts of the world, particularly in low-and middle-income countries. This trend largely reflects the adoption of a Western lifestyle, including changes in diet, physical activity, and reproductive patterns. The growth and ageing of the population are predicted to further drive increases in the global burden of breast cancer, particularly in low and middle-income countries. In low resource settings, down staging of symptomatic disease is considered more beneficial and cost-effective than screening for asymptomatic disease. However, misconceptions about the nature or curability of breast cancer are still prevalent in many communities. Thus, it is necessary to increase awareness about breast cancer and the benefits of early detection, most notably in transitioning countries, to successfully implement breast cancer control programs, as well as to improve access to treatment.
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